This public procurement record has 2 releases in its history.

Award

19 Apr 2021 at 13:15

Tender

05 Nov 2020 at 14:04

Summary of the contracting process

The Public Health England (PHE) initiated the National Microbiology Framework procurement, focused on Diagnostic Goods and Services, which encompasses the supply of in vitro diagnostic medical devices and related services. This open tender, designated for a duration of two years, with potential extensions of an additional two years, concluded its tender period on 7th December 2020. The overall estimated value for this framework is approximately £22 billion. The contract's scope includes enhanced services and products in the medical equipment and pharmaceuticals sector, facilitating operations across the UK and beyond.

This procurement offers significant opportunities for businesses looking to supply diagnostic equipment and services. Companies involved in medical equipment, pharmaceuticals, and clinical laboratory services are particularly well-suited to compete for this framework. Given the framework's focus on innovation and the rapid advancement of diagnostic technologies, suppliers who can present new, compliant products and respond adeptly to market demands are likely to thrive. This tender represents a gateway for both established firms and SMEs, keen to expand their footprint in the public health sector.

How relevant is this notice?

Notice Title

National Microbiology Framework - Lot 1: Diagnostic Goods and Services

Notice Description

Lot 1 - Diagnostic Goods and Services is for the supply of in vitro diagnostic medical devices and associated services including equipment, consumables, maintenance, and peripheral equipment and associated services. All reagents and consumables comply with current CE regulations (UKCA regulations when applicable) and must retain the CE mark (or, once superseded, the UKCA mark) for the duration of the Framework and any potential extensions. This Lot includes provisions for reagent rental and managed equipment services. Please note that this Award Notice is for Lot 1, however the Framework Agreement encompasses the following four lots: - Lot 1: Diagnostic Goods and Services - Lot 2: Research and Development Goods and Services - Lot 3: Manufacturing, Product Development and Commercialisation - Lot 4: Clinical Laboratory Diagnostic Testing Services Additional information: The term of the framework is for an initial 2 years with options to extend by up to a further 2 years. The value attributed to each Lot is an approximate estimate only, the actual values will be to such level as those purchasing under the Framework Agreement consider necessary to provide suitable requirements. The scope of this Framework Agreement covers Goods and Services that are subject to rapid and frequent improvements, advancements and new scientific and technical developments. Therefore, to keep this Framework Agreement in line with the latest market and scientific developments so as to ensure that patients and other end users have ongoing access to state of the art diagnostics for the duration of this Framework Agreement successful Suppliers will be able to propose new and/or updated Goods and/or Services to be added to a Supplier's range under the Framework Agreement if one or more of the following circumstances apply: - Where the proposed updated Goods or Services fall within the general scope of this procurement as set out as part of this OJEU Contract Notice (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the description sections of this Contract Notice); - Where the proposed new Goods or Services fall within the broad categories of Goods or Services covered by this Framework Agreement (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice), but are new to the market. For the avoidance of doubt, for the purposes of any testing services, this will allow Suppliers to offer new types of tests, new test kits, related new equipment / products, related new consumables and related new Services as and when they become available during the duration of the Framework Agreement provided they fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice); - Where the proposed new or updated Goods or Services reflect a product or service line extension (i.e. are new, modified or updated products or services in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement); or - Where the proposed new or updated Goods or Services reflect a range extension (i.e. are new, modified or updated products or services that reflect an expansion of the Supplier's range in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement).

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-f7d14908-7da1-4faa-8801-324f837a758e
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/c87ea5c3-e23f-4432-9bc1-996a39f1cc48
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33000000 - Medical equipments, pharmaceuticals and personal care products

33100000 - Medical equipments

33124100 - Diagnostic devices

Notice Value(s)

Tender Value
£3,000,000,000 £1B-£10B
Lots Value
Not specified
Awards Value
£3,000,000,000 £1B-£10B
Contracts Value
Not specified

Notice Dates

Publication Date
19 Apr 20215 years ago
Submission Deadline
7 Dec 2020Expired
Future Notice Date
Not specified
Award Date
8 Mar 20215 years ago
Contract Period
9 Apr 2021 - 8 Apr 2023 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
Public Health England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
NW9 5EQ
Postcode Area
North West London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI7 Outer London - West and North West
Small Region (ITL 3)
TLI71 Barnet
Delivery Location
Not specified

Local Authority
Barnet
Electoral Ward
Colindale South
Westminster Constituency
Hendon

Supplier Information

Number of Suppliers
112
Supplier Names

Mornington 2000 LLP

A.Menarini Diagnostics Ltd

AB Molecular Limited

AB Scientific Limited

Abbott Laboratories Ltd

Abbott Rapid Diagnostics Limited

AESKU.UK Ltd

Agena Bioscience GmbH

Alpha Laboratories Ltd

Alphabiolaboratories Analytical Limited

Altona Diagnostics UK Ltd

Appleton Woods Ltd

AusDiagnostics UK Ltd

Beckman Coulter United Kingdom Limited

Becton Dickinson U.K. Limited

BGI Genomics UK CO LTD

BioConnections Ltd

BIOMERIEUX UK LIMITED

Eurofins Biomnis UK Ltd

Bio-Rad Laboratories Limited

Bioserv UK Limited

BioSure (UK) Ltd

Bruker UK Limited

Cambridge Bioscience Ltd

Cambridge Life Sciences Limited

Cepheid UK Ltd

Cerescom Ltd and Cargo Services Far East

Chase Madison

Chirus Limited

Connect2pharma Ltd

Diasorin Limited

DnaNudge Limited

Don Whitley Scientific Limited

Elitech UK Limited

Euroimmun UK Ltd

Europlaz Technologies Ltd

Excalibur Healthcare Services

Genedrive Diagnostics Ltd

GeneFirst Limited

GENETIC SIGNATURES (UK) LIMITED

Greiner Bio-One Ltd

Grifols UK Ltd

Healthlinked Ltd

Hologic LTD.

HORIBA UK Limited

Hymon International (UK) Ltd

IDvet

Illumina Cambridge Limited

Immensa Health Clinic Ltd

Intertek Testing & Certification Limited

Invitech Ltd

LabMediaServis s.r.o.

Launch Diagnostics Ltd

SeraCare Life Sciences, Inc., dba LGC Clinical Diagnostics

Life Technologies Ltd

Luminex Corporation

LumiraDx

Malvern Medical Developments Ltd

Mast Group Ltd

Medical Wire & Equipment

Medline Scientific Limited

Medusa19 Healthcare Limited

MGI International Sales Co. Ltd

Microgen Bioproducts Ltd

Mobidiag UK Ltd

MultiplexDX, s.r.o.

nal von minden GmbH

OptiGene Limited

Origin Packaging Ltd

Ortho Clinical Diagnostics

OscarTech UK Ltd

Oxford Biosystems Ltd

Oxford Immunotec Ltd

Oxford Nanopore Technologies Ltd

Eurobio Scientific UK Limited

Revvity (UK) Limited

Primerdesign Ltd

Microlink Technology Limited

Promega UK Ltd

QIAGEN Ltd

QuantuMDx Group Limited

Quidel Ireland Ltd

Randox Laboratories Ltd

Rapid Labs Limited

R-Biopharm Rhone Ltd

Roche Diagnostics Ltd

RTA Laboratuvarlari

Scientific Laboratory Supplies Limited

Serosep UK Limited

Siemens Healthcare Diagnostics Ltd

SpeeDx Ltd

SPT LABTECH LIMITED

Stratech Scientific Ltd

SureScreen Diagnostics Ltd

Sysmex UK Limited

Tanner Pharma UK Limited

Tecan UK Limited

Technopath Distribution Ltd

Teva UK Limited

The Binding Site Group Limited

Thermo Fisher Diagnostics Limited

Sterilin Ltd

TMC Worldnetwork Ltd

UKOS Ltd

Una Health Ltd

Vectornate UK Ltd

VH Bio

VWR International Ltd

Werfen Ltd

Wolf Laboratories Limited

Wuhan HealthCare Biotechnology Co., Ltd

Yourgene Health UK

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...